SCHEMBL29494235

SCHEMBL29494235

Cc1ccc(NC(=O)CN2CCN(CCO)CC2)cc1C(=O)N[C@H](C)c1cccc2ccccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494397 0.93 CYP2C19 (0.53) —
SCHEMBL29494262 0.90 CYP2C19 (0.49) —
SCHEMBL29494451 0.90 — —
Trifluoroacetic Acid SCHEMBL29494443 0.88 CYP2C19 (0.47) —
SCHEMBL29494410 0.87 — —
SCHEMBL29494384 0.86 DRD4 (0.56) —
Trifluoroacetic Acid SCHEMBL29494362 0.86 — —
Trifluoroacetic Acid SCHEMBL29494370 0.85 — —
SCHEMBL24731381 0.84 — —
SCHEMBL29138187 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO claimed
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO disclosed
Send feedback